Skip to Content

Congressional Record E687: Introduction of the Pathway for Biosimilars Act, Hon. Anna G. Eshoo

U.S. Government Printing Office
March 17, 2009

INTRODUCTION OF THE PATHWAY FOR BIOSIMILARS ACT HON. ANNA G. ESHOO OF CALIFORNIA IN THE HOUSE OF REPRESENTATIVES Tuesday, March 17, 2009

H.R. 1427, “Promoting Innovation and Access to Life-Saving Medicine Act”

U.S. House of Representatives
March 11, 2009

111TH CONGRESS 1ST SESSION H. R. 1427 To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes. IN THE HOUSE OF REPRESENTATIVES MARCH 11, 2009

Senate Hearing on President’s Fiscal Year 2010 Health Care Proposals

U.S. Senate, Committee on Finance
March 10, 2009

S. HRG. 111-828 PRESIDENT'S FISCAL YEAR 2010 HEALTH CARE PROPOSALS HEARING BEFORE THE COMMITTEE ON FINANCE UNITED STATES SENATE ONE HUNDRED ELEVENTH CONGRESS FIRST SESSION MARCH 10, 2009

Amendment to S. 1695, “Biologics Price Competition and Innovation Act of 2007”

U.S. Senate
November 19, 2008

110TH CONGRESS 2D SESSION S. 1695 To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. IN THE SENATE OF THE UNITED STATES JUNE 26, 2007 Mr. KENNEDY (for himself, Mr. HATCH, Mrs. CLINTON,

Amendment of S. 1695, “Biologics Price Competition and Innovation Act of 2007”

U.S. Senate
November 19, 2008

110TH CONGRESS 2D SESSION II Calendar No. 1127 S. 1695 To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. IN THE SENATE OF THE UNITED STATES JUNE 26, 2007 Mr. KENNEDY (for himself, Mr.

H.R. Hearing on Getting Better Value in Health Care

U.S. House of Representatives, Committee on the Budget
July 16, 2008

GETTING BETTER VALUE IN HEALTH CARE HEARING BEFORE THE COMMITTEE ON THE BUDGET HOUSE OF REPRESENTATIVES ONE HUNDRED TENTH CONGRESS SECOND SESSION HEARING HELD IN WASHINGTON, DC, JULY 16, 2008 Serial No. 110–37

H.R. 5629, “Pathway for Biosimilars Act”

U.S. House of Representatives
March 13, 2008

110TH CONGRESS 2D SESSION H. R. 5629 To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes. IN THE HOUSE OF REPRESENTATIVES MARCH 13, 2008

Congressional Record E401: Introduction of the Pathway for Biosimilars Act, Hon. Anna G. Eshoo

U.S. Government Printing Office
March 13, 2008

INTRODUCTION OF THE PATHWAY FOR BIOSIMILARS ACT HON. ANNA G. ESHOO OF CALIFORNIA IN THE HOUSE OF REPRESENTATIVES Thursday, March 13, 2008

S. 1695, “Biologics Price Competition and Innovation Act of 2007”

U.S. Senate
June 26, 2007

110TH CONGRESS 1ST SESSION S. 1695 To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. IN THE SENATE OF THE UNITED STATES JUNE 26, 2007

S. 1505, “Affordable Biologics for Consumers Act”

U.S. Senate
May 24, 2007

110TH CONGRESS 1ST SESSION S. 1505 To amend the Public Health Service Act to provide for the approval of biosimilars, and for other purposes. IN THE SENATE OF THE UNITED STATES MAY 24, 2007